Similarly, mice with HSC-specific ablation of Fip200 and Atg5 have shown significant reduction in HSCs, increased ROS and HSC proliferation, decreased HSC reconstitution ability in the bone marrow, and survival defects including severe anemia and lymphopenia [167, 168]. Here, ATG5 is linked to anemia.